RE104 for Injection
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Reunion Neuroscience Inc
Overview
RE104 for Injection is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
RE104 for Injection clinical trials
Explore related
Medical disclaimer. This page summarizes research about RE104 for Injection for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.